Position in LH
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$10,147,851
+$9,435,603 QoQ
Shares Held
38,034
+1239.7% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026FIL Ltd holds $956,351,387 across 14 Diagnostics & Research names. LH ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
2,096,221 | $397,443,501 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
531,867 | $261,428,585 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
745,630 | $127,159,740 | |
| 4 | QGEN |
Qiagen N.V.
|
1,577,141 | $63,148,725 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
38,050 | $47,988,660 | |
| 6 | DGX |
Quest Diagnostics Inc
|
86,569 | $16,965,792 | |
| 7 | LH |
Labcorp Holdings Inc.
This page
|
38,034 | $10,147,851 | |
| 8 | MEDP |
Medpace Holdings, Inc.
|
18,227 | $8,752,422 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $10,147,851 | 38,034 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $712,248 | 2,839 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,418,363 | 4,941 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $82,366,975 | 313,767 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $88,924,135 | 382,075 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $87,702,058 | 382,444 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $87,686,176 | 392,367 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $80,975,407 | 397,894 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||